On 6/26/2008 6:40:16 PM, michelle hamel ([email protected])
wrote:
> Hi again--
> Chuck, have you se the research that DMSO caused cataracts in dog and
> rabbit
> eyes? If you google DMSO and floaters it should pop up. Let me know
> what
> you think. Thanks!
> Michelle
>
I refer you to
DMSO: Nature's Healer by Morton Walker
also
The works of Dr Stanly Jacob
and
------------------------------------------------------------------------
"The Human Toxicology Of Dimethyl Sulfoxide
Richard D. Brobyn
Bainbridge Medical Center Bainbridge Island, Washington
INTRODUCTION
On November 11, 1965, research on DMSO in the United States came to an
abrupt halt. A conference between the Food and Drug Administration and
the pharmaceutical companies who were involved in the research was
called because lens changes had been observed in a number of mammalian
species. No changes ha been observed in man or any primates. The FDA
and the pharmaceutical companies agreed, because there had been no
pretreatment examinations of eyes and a large number of patients were
under therapy, to discontinue the clinical studies: Somehow, at this
time, DMSO gained a reputation of extreme toxicity, comparable to that
of thalidomide and some other drugs that had previously run into major
toxicology problems. Many of us in the pharmaceutical industry felt
that this reputation was undeserved.
A refractive index change in the lens (not an opacity) had been
observed after ? months at a dose of approximately 5 g/kg in dogs,
rabbits, and pigs. No microscopic or chemical differences could be
found between the lenses of the treated animals am the controls. In
the affected animals, there appeared two distinct zones of different
refraction. This could easily by observed with an ophthalmoscope and
with the slit lamp. It appeared to be a dose-related effect, and it
diminished as the dose was reduced. It is noteworthy that the effect
was produced at 50 to l00 times the usual human therapeutic dose.
In November, 1965 there had been no cases of confirmed eye damage or
significant complaints in the studies of any of the pharmaceutical
firms. Pre-treatment examinations of eyes had not been performed. We
all felt that to re-examine all the patients who had been under
treatment at this stage would be fruitless exercise, because of the
age of many of the patients and their preexisting eye problems. We
elected, therefore, to check certain long-term patients on high doses.
Drs. Jacob and Rosenbaum, in Portland, Oregon, had 32 patients
examined by ophthalmologists connected with the University of Oregon
Medical School. These had been treated for from 3 to 19 months, at an
average dose of 30 g DMSO per day. None of these showed any of the
characteristic lens changes that had been seen in the animals. One
patient in Seattle was thoroughly checked. He had by chance had a
complete pretreatment examination performed by an ophthalmologist
several months prior to his neck injury. He was 19 years old, and at
the date of his post-treatment exam he had received 60 g DMSO per day
for 20 months. His follow-up exam was completely negative. This
included tonometry, visual field, refraction, and slit lamp
examination."
-------------------------------------------------------------------
But, I maintain that as we are all responsible for our own well being,
the choices we make are our own.
It's a shame to be frozen immobile by indecision.
Do as you deem prudent.
Chuck
Bite off one chicken head and they never let you forget
No virus found in this outgoing message.
Checked by AVG.
Version: 8.0.100 / Virus Database: 270.4.1/1519 - Release Date: 6/25/2008 4:13
PM
